Follow
Devis Pascut
Devis Pascut
Fondazione Italiana Fegato ONLUS
Verified email at fegato.it - Homepage
Title
Cited by
Cited by
Year
Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma
CHC Sukowati, N Rosso, D Pascut, B Anfuso, G Torre, P Francalanci, ...
BMC gastroenterology 12, 1-8, 2012
652012
The crosstalk between tumor cells and the microenvironment in hepatocellular carcinoma: The role of exosomal microRNAs and their clinical implications
D Pascut, MY Pratama, NVT Vo, R Masadah, C Tiribelli
Cancers 12 (4), 823, 2020
502020
Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma
RB Ladju, D Pascut, MN Massi, C Tiribelli, CHC Sukowati
Oncotarget 9 (2), 2951, 2018
472018
The role of microRNA in the resistance to treatment of hepatocellular carcinoma
MY Pratama, D Pascut, MN Massi, C Tiribelli
Annals of translational medicine 7 (20), 2019
422019
Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma
D Pascut, CHC Sukowati, G Antoniali, G Mangiapane, S Burra, ...
Oncotarget 10 (3), 383, 2019
422019
A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients
D Pascut, H Krmac, F Gilardi, R Patti, R Calligaris, LS Crocè, C Tiribelli
Scientific Reports 9 (1), 8265, 2019
402019
Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients
E Gurian, A Di Silvestre, E Mitri, D Pascut, C Tiribelli, M Giuffrè, LS Crocè, ...
Analytical and bioanalytical chemistry 413, 1303-1312, 2021
332021
Serum miRNA are promising biomarkers for the detection of early hepatocellular carcinoma after treatment with direct-acting antivirals
D Pascut, L Cavalletto, MY Pratama, S Bresolin, L Trentin, G Basso, ...
Cancers 11 (11), 1773, 2019
332019
Circulating long and circular noncoding RNA as non-invasive diagnostic tools of hepatocellular carcinoma
CHC Sukowati, LKD Cabral, C Tiribelli, D Pascut
Biomedicines 9 (1), 90, 2021
322021
The role of microRNAs in the cisplatin-and radio-resistance of cervical cancer
R Masadah, S Rauf, MY Pratama, C Tiribelli, D Pascut
Cancers 13 (5), 1168, 2021
292021
Serum stem cell growth factor beta for the prediction of therapy response in hepatocellular carcinoma
CHC Sukowati, R Patti, D Pascut, RB Ladju, P Tarchi, N Zanotta, M Comar, ...
BioMed Research International 2018, 2018
252018
Circulatory miRNA as a biomarker for therapy response and disease-free survival in hepatocellular carcinoma
MY Pratama, A Visintin, LS Crocè, C Tiribelli, D Pascut
Cancers 12 (10), 2810, 2020
232020
Weighted miRNA co-expression networks analysis identifies circulating miRNA predicting overall survival in hepatocellular carcinoma patients
D Pascut, MY Pratama, F Gilardi, M Giuffrè, LS Crocè, C Tiribelli
Scientific reports 10 (1), 18967, 2020
212020
HCV Proteins modulate the host cell miRNA expression contributing to Hepatitis C pathogenesis and Hepatocellular Carcinoma Development
D Pascut, M Hoang, NNQ Nguyen, MY Pratama, C Tiribelli
Cancers 13 (10), 2485, 2021
182021
Silencing efficacy prediction: a retrospective study on target mRNA features
D Pascut, G Bedogni, C Tiribelli
Bioscience reports 35 (2), e00185, 2015
182015
HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance
D Pascut, MY Pratama, C Tiribelli
Hepatic Oncology 7 (2), HEP21, 2020
102020
Differences in circulating microRNA signature in Prader–Willi syndrome and non-syndromic obesity
D Pascut, S Tamini, S Bresolin, P Giraudi, G Basso, A Minocci, C Tiribelli, ...
Endocrine Connections 7 (12), 1262-1274, 2018
102018
MicroRNAs related to TACE treatment response: a review of the literature from a radiological point of view
AM Bozzato, P Martingano, RA Pozzi Mucelli, MFM Cavallaro, ...
Diagnostics 12 (2), 374, 2022
92022
Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs
CHC Sukowati, B Anfuso, D Pascut, C Tiribelli
Expert Review of Gastroenterology & Hepatology 9 (6), 723-725, 2015
92015
Selection and validation of miR-1280 as a suitable endogenous normalizer for qRT-PCR Analysis of serum microRNA expression in Hepatocellular Carcinoma
MY Pratama, L Cavalletto, C Tiribelli, L Chemello, D Pascut
Scientific Reports 10 (1), 3128, 2020
82020
The system can't perform the operation now. Try again later.
Articles 1–20